MIGDAL HAEMEQ, Israel—Enzymotec Ltd. received Frost & Sullivan’s “2011 Global Phosphatidylserine Customer Value Enhancement Award" for implementing strategies that proactively create value for its customers.
“We are pleased to be presented with this award, which puts forward the unique value we provide our customers with," said Boaz Noy, head of bioactive ingredients division. “Namely, our innovative and proactive approach to customers’ needs and business objectives."
Poshpatidylserine (PS) is a natural nutrient found in the cell membrane and particularly abundant in the brain. It has shown benefits for cognitive function, such as: concentration, focus, learning and memory especially with elderly adults. PS is the only ingredient that has been granted with a qualified health claim by the FDA, related to cognitive dysfunction and dementia in the elderly. Earlier this month, Sharp PS®, a soy-PS ingredient from Enzymotec, received novel food approval from the European Commission (EC), which allows the marketing and use of Sharp PS in a wide selection of foods and beverages in Europe.
In that category, Enzymotec has launched Soy-free PS and PS-Omega 3 conjugates, and supported clinical trials that has shown PS’s effect on early Alzheimer’s Disease and attention deficit hyperactivity disorder (ADHD).
Noy added he believes success come form best-in-class solutions and the delivery of value-added products and services to clients. “The dietary supplement industry is characterized with highly competitive markets, rapidly evolving technologies and high customer expectations."
Enzymotec, a biotech company and a global developer, is a manufacturer and supplier of lipid-based products and solutions. Enzymotec develops, produces and markets innovative bioactive ingredients and finished products based on proprietary technologies. Enzymotec's products support general health, from cardiovascular to cognitive functions.
